VOR

Vor Biopharma Stock Analysis

AI Rating

Neutral
  • Quality4/10
  • Growth↓ 0/10
  • Momentum↑ 9/10
Vor Biopharma sales and earnings growth
VOR Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -1076.96%
  • FCF Y/Y↓ -44.03%
Vor Biopharma gross and profit margin trends
VOR Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -10196.70%
Vor Biopharma net debt vs free cash flow
VOR Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Vor Biopharma stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗